ROCKET LAB USA INC (RKLB)
US7731221062 - Common Stock
We assign a fundamental rating of 3 out of 10 to RKLB. RKLB was compared to 63 industry peers in the Aerospace & Defense industry. The financial health of RKLB is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RKLB is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RKLB had negative earnings in the past year.
RKLB had a negative operating cash flow in the past year.
In the past 5 years RKLB always reported negative net income.
RKLB had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -19.40%, RKLB is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
RKLB has a Return On Equity of -32.92%. This is in the lower half of the industry: RKLB underperforms 63.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.4% | ||
| ROE | -32.92% | ||
| ROIC | N/A |
ROA(3y)-15.03%
ROA(5y)-17.99%
ROE(3y)-23.3%
ROE(5y)-28.61%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RKLB's Gross Margin of 21.02% is in line compared to the rest of the industry. RKLB outperforms 47.62% of its industry peers.
The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RKLB has been increased compared to 1 year ago.
RKLB has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.03 indicates that RKLB is not a great score, but indicates only limited risk for bankruptcy at the moment.
RKLB's Altman-Z score of 2.03 is in line compared to the rest of the industry. RKLB outperforms 47.62% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that RKLB is not too dependend on debt financing.
RKLB has a Debt to Equity ratio of 0.19. This is in the better half of the industry: RKLB outperforms 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.03 |
ROIC/WACCN/A
WACC9.4%
2.3 Liquidity
RKLB has a Current Ratio of 2.13. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
RKLB has a Current ratio of 2.13. This is comparable to the rest of the industry: RKLB outperforms 58.73% of its industry peers.
RKLB has a Quick Ratio of 1.65. This is a normal value and indicates that RKLB is financially healthy and should not expect problems in meeting its short term obligations.
RKLB has a Quick ratio of 1.65. This is in the better half of the industry: RKLB outperforms 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
RKLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.00%.
RKLB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.93%.
Measured over the past years, RKLB shows a very strong growth in Revenue. The Revenue has been growing by 90.82% on average per year.
EPS 1Y (TTM)-52%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-25%
Revenue 1Y (TTM)15.93%
Revenue growth 3Y90.82%
Revenue growth 5YN/A
Revenue growth Q2Q15.9%
3.2 Future
RKLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.81% yearly.
RKLB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 47.36% yearly.
EPS Next Y-11.66%
EPS Next 2Y27.87%
EPS Next 3Y40.13%
EPS Next 5Y36.81%
Revenue Next Year73.28%
Revenue Next 2Y59.66%
Revenue Next 3Y56.14%
Revenue Next 5Y47.36%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RKLB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKLB. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
RKLB's earnings are expected to grow with 40.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.87%
EPS Next 3Y40.13%
5. Dividend
5.1 Amount
RKLB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ROCKET LAB USA INC
NASDAQ:RKLB (5/3/2024, 7:15:51 PM)
After market: 4.01 +0.01 (+0.25%)4
+0.05 (+1.27%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.96B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.4% | ||
| ROE | -32.92% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 21.02% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.13 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-52%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-11.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.93%
Revenue growth 3Y90.82%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y